Speak To An Expert
Get clear, personalised advice for your situation.
Jot down a few questions to make the most of your conversation.
Why stopping matters
Weight loss jabs such as Wegovy, Mounjaro and Saxenda can help reduce appetite and support weight loss, but many people regain weight after stopping them. In the UK, it is important to think about the longer-term plan before coming off treatment.
Stopping suddenly may also mean that any benefits for blood sugar control, blood pressure or cholesterol start to fade. For some people, that change can happen quite quickly, especially if lifestyle support is not in place.
People with type 2 diabetes
People with type 2 diabetes should be particularly cautious about stopping weight loss jabs, especially if the medicine is also helping to control blood glucose. Some of these treatments are used alongside other diabetes medicines, so changing one drug can affect overall control.
If blood sugar rises after stopping, there may be a higher risk of symptoms such as thirst, tiredness and frequent urination. It is sensible to speak to a GP, diabetes nurse or prescribing clinician before making any changes.
People taking other medicines
Anyone taking medicines for diabetes, high blood pressure or heart disease may need extra advice before stopping a weight loss jab. Weight loss can change how these conditions are managed, and stopping treatment may alter the doses needed for other medicines.
This is especially important for people who have had recent medication changes or who are using insulin or tablets that can cause low blood sugar. A clinician can help review whether any monitoring or dose adjustments are needed.
People with a history of eating disorders
People who have had anorexia, bulimia or binge eating disorder should be cautious. Appetite-suppressing medicines can sometimes affect eating patterns and body image, so stopping them may be emotionally difficult or trigger a return of symptoms.
Support from a GP, therapist or specialist weight management service can be helpful. If there is any concern about disordered eating, a joined-up approach is usually safest.
People with severe obesity or related health problems
People living with severe obesity, sleep apnoea, fatty liver disease or mobility problems may also need to plan carefully. For them, weight regain after stopping treatment could worsen existing health issues.
That does not mean they must stay on treatment forever, but it does mean the decision should be made with medical advice. A gradual transition to diet, activity and ongoing support may reduce the risk of rebound weight gain.
When to get advice before stopping
Anyone who is pregnant, breastfeeding, planning surgery, or has troublesome side effects should seek advice before stopping. The same applies if the jab is being used privately and there is no regular NHS review in place.
In the UK, the best first step is usually a conversation with the prescriber or GP. They can explain whether it is safe to stop, whether tapering is needed, and what follow-up support should be arranged.
Frequently Asked Questions
Weight loss jabs are generally not recommended during pregnancy, and people trying to conceive should discuss stopping timing with a clinician before stopping contraception or starting fertility plans.
People who are breastfeeding should usually avoid these medicines unless a clinician advises otherwise, because safety data are limited and stopping or switching should be planned with medical guidance.
People with type 2 diabetes may need monitoring when stopping because blood sugar can rise, and other glucose-lowering treatment may need adjustment to prevent hyperglycaemia.
If the jabs are stopped, insulin or sulfonylurea doses may need review to reduce the risk of blood sugar swings, especially if appetite and food intake change at the same time.
Anyone with a history of pancreatitis should discuss stopping and future use with a specialist, since abdominal symptoms after stopping or restarting need prompt assessment.
People with gallstones or gallbladder problems should seek medical advice before stopping if they have abdominal pain, nausea, or jaundice, because these symptoms may need urgent evaluation.
If someone has persistent vomiting, dehydration, or severe abdominal pain, the medicine should not be restarted without medical review and hydration status should be assessed first.
People with kidney disease should be monitored carefully when stopping because dehydration from gastrointestinal side effects can affect kidney function, and any ongoing symptoms should be reviewed quickly.
People with liver disease should not make changes without clinician advice, especially if they have poor intake, nausea, or signs of worsening illness that could affect medication safety.
Older frail adults may need closer supervision when stopping because appetite, hydration, and muscle loss can be affected, and the plan should be tailored to overall health and nutrition.
Anyone with a current or past eating disorder should stop only with professional support, because changes in appetite, weight, and body image can be distressing and medically risky.
Use in children and adolescents should be specialist-led, and stopping should be supervised to monitor growth, nutrition, mental wellbeing, and any return of weight-related issues.
People with cardiovascular disease should discuss stopping with a clinician, especially if the medicine was helping weight control, blood pressure, or diabetes management that affects heart risk.
People planning surgery should inform their surgical team early, because stopping timing may need to be coordinated with fasting rules, anaesthesia plans, and postoperative nausea risk.
A personal or family history of medullary thyroid cancer requires specialist advice before any decision to continue, stop, or restart, since this is a key safety concern for some medicines.
Immunocompromised people should ask a clinician before stopping because illness, poor oral intake, or infection can change hydration and blood sugar management, and symptoms should be assessed promptly.
People with anxiety, depression, or other mental health concerns should have a stopping plan that includes mood monitoring, because appetite and weight changes can affect psychological wellbeing.
If appetite remains very low or eating is difficult after stopping, the person should seek medical advice, as dehydration, malnutrition, or another illness may need evaluation.
Restarting after a break should be done according to the product instructions and clinician advice, because dose re-titration may be needed to reduce side effects in specific populations.
People taking other long-term medicines should ask a clinician or pharmacist before stopping, because changes in weight, appetite, and digestion can alter how other treatments work.
Useful Links
Ergsy Search Results
This website offers general information and is not a substitute for professional advice.
Always seek guidance from qualified professionals.
If you have any medical concerns or need urgent help, contact a healthcare professional or emergency services immediately.
Some of this content was generated with AI assistance. We've done our best to keep it accurate, helpful, and human-friendly.
- Ergsy carefully checks the information in the videos we provide here.
- Videos shown by Youtube after a video has completed, have NOT been reviewed by ERGSY.
- To view, click the arrow in centre of video.
- Most of the videos you find here will have subtitles and/or closed captions available.
- You may need to turn these on, and choose your preferred language.
- Go to the video you'd like to watch.
- If closed captions (CC) are available, settings will be visible on the bottom right of the video player.
- To turn on Captions, click settings.
- To turn off Captions, click settings again.